Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-β1 in inducing c-fms expression

Cancer Research

Volumn 67, Issue 5, 2007, Pages 1918-1926

  Kirma, Nameer ^a   Hommes, Luciano S ^a,b   Liu, Ya Guang ^a   Nair, Hareesh B ^a   Valente, Philip T ^a   Kumar, Shantha ^c   Flowers, Lisa C ^c   Tekmal, Rajeshwar Rao ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTOCRINE EFFECT; CANCER INVASION; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

APOPTOSIS; CARCINOMA; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 33947204592     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1991     Document Type: Article

References (40)

1. American Cancer Society. Cancer facts and figures 2005. Atlanta (GA): American Cancer Society; 2005.
2. Davidson B, Goldberg I, Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract 1997;193:491-5.
3. Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer 1998;83:788-96.
4. Rettenmier CW, Chen JH, Roussel MF, Sherr CJ. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 1985; 228:320-2.
5. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 1991;67:990-6.
6. Kascinski B. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat Res 2002;107:285-92.
7. Toy EP, Chambers JT, Kacinski BM, Flick MB, Chambers SK. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;80:194-200.
8. Smith HO, Anderson PS, Kuo DY, et al. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1995;1:313-25.
9. Tang B, Vu M, Booker T, et al. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003; 112:1116-24.
10. Chin BY, Petrache I, Choi AM, Choi ME. Transforming growth factor β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J Biol Chem 1999;274:11362-8.
11. Arsura M, Panta GR, Bilyeu JD, et al. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 2003;22:412-25.
12. Kloth JN, Fleuren GJ, Oosting J, et al. Substantial changes in gene expression of Wnt, MAPK, and TNFα pathways induced by TGF-β1 in cervical cancer cell lines. Carcinogenesis 2005;26:1493-502.
13. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J Biol Chem 1999;274:27161-7.
14. Serra R, Crowley MR. Mouse models of transforming growth factor β impact in breast development and cancer. Endocr Relat Cancer 2005;12:749-60.
15. Kang Y, He W, Tulley S, et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A 2005;102:13909-14.
16. Kaminska B, Wesolowska A, Danilkiewicz M. TGF β signalling and its role in tumour pathogenesis. Acta Biochim Pol 2005;52:329-37.
17. Inaba T, Ishibashi S, Harada K, et al. Synergistic effects of transforming growth factor-β on the expression of c-fms, macrophage colony-stimulating factor receptor gene, in vascular smooth muscle cells. FEBS Lett 1996;399:207-10.
18. Chen AR, Rohrschneider LR. Mechanism of differential inhibition of factor-dependent cell proliferation by transforming growth factor-β1: selective uncoupling of FMS from MYC. Blood 1993;81:2539-46.
19. Adam RA, Horowitz IR, Tekmal RR. Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia. Am J Obstet Gynecol 1999;180:28-32.
20. Suzuki M, Ohwada M, Sato I, Nagatomo M. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies. Oncology 1995;52: 128-33.
21. Ngan HY, Liu SS, Yu H, Liu KL, Cheung AN. Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. Eur J Cancer 1999;35:1546-50.
22. Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 1995;48:876-8.
23. Calatayud S, Warner TD, Breese EJ, Mitchell JA. Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosis. Cytokine 2002;20: 163-7.
24. Gill K, Kirma N, Gunna VS, Santanam N, Parthasarathy S, Tekmal RR. Regulation of colony stimulating factor-1 (CSF-1) in endometrial cells: glucocorticoids and oxidative stress regulate the expression of CSF-1 and its receptor c-fms in endometrial cells. Fertil Steril 2001;76: 1005-11.
25. Keshava N, Gubba S, Tekmal RR. Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis. J Soc Gynecol Investig 1999;6:41-9.
26. Dewar AL, Cambareri AC, Zannettino AC, et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 2005;105:3127-32.
27. Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J Cell Biol 2004;165:263-73.
28. Kang SH, Won K, Chung HW, et al. Genetic integrity of transforming growth factor β(TGF-β) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-β. Int J Cancer 1998;77:620-5.
29. Park JI, Lee MG, Cho K, et al. Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-κB, JNK, and Ras signaling pathways. Oncogene 2003;32:4314-32.
30. Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 2005;7:509-21.
31. El-Sherif AM, Seth R, Tighe PJ, Jenkins D. Decreased synthesis and expression of TGF-β1, β2, and β3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry. J Pathol 2000;192:494-501.
32. Xu Q, Wang S, Xi L, et al. Effects of human papillomavirus type 16 E7 protein on the growth of cervical carcinoma cells and immuno-escape through the TGF-β1 signaling pathway. Gynecol Oncol 2006;101:132-9.
33. Kacinski BM, Scata KA, Carter D, et al. FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 1991;6:941-52.
34. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
35. Heller DS, Hameed M, Cracchiolo B, et al. Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int J Gynecol Cancer 2003;13: 67-70.
36. Goswami S, Sahai E, Wyckoff JB, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005;65:5278-83.
37. Rosenfeld CS. Transforming growth factor-β1 augments macrophage-colony stimulating factor activity on human marrow. Stem Cells 1994;12:527-32.
38. Farley J, Gray K, Nycum L, Prentice M, Birrer MJ, Jakowlew SB. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-β and a contrasting decrease in p27(Kip1). Gynecol Oncol 2000;78:113-22.
39. Hazelbag S, Gorter A, Kenter GG, van den Broek L, Fleuren G. Transforming growth factor-β1 induces tumor stroma and reduces tumor infiltrate in cervical cancer. Hum Pathol 2002;33:1193-9.
40. Soufla G, Sifakis S, Baritaki S, Zafiropoulos A, Koumantakis E, Spandidos DA. VEGF, FGF2, TGFB1, and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett 2005;221:105-18.